| Charles C Cheng, MD | |
|
1818 N Meade St, Suite 240 West, Appleton, WI 54911-3454 | |
| (920) 731-8289 | |
| (920) 832-0444 |
| Full Name | Charles C Cheng |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 30 Years |
| Location | 1818 N Meade St, Appleton, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285626465 | NPI | - | NPPES |
| 34128600 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 43500 020 (Wisconsin) | Primary |
| 2086X0206X | Surgery - Surgical Oncology | 43500 020 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Thedacare Regional Medical Center - Appleton Inc | Appleton, WI | Hospital |
| Ascension Ne Wisconsin - St Elizabeth Campus | Appleton, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fox Valley Surgical Associates Ltd | 7911971296 | 28 |
News Archive
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the launch of the ICOLabs Medical Review Application an innovative web based laboratory application that enables more efficient use of medical monitoring time.
Novartis announced today that the results of the MEASURE 1 and MEASURE 2 Phase III studies for Cosentyx® (secukinumab) in ankylosing spondylitis (AS) were published in The New England Journal of Medicine (NEJM). These pivotal studies demonstrated significant clinical improvements with Cosentyx versus placebo in reducing the signs and symptoms of active AS – a long-term, painful and debilitating inflammation of the spine.
A new study has demonstrated a way to deliver a nanoparticle-based gene therapy, in order to repair lungs damaged by chronic allergic asthma and to reduce inflammation that causes asthma attacks.
TxCell SA, a biotechnology company developing innovative, personalized T cell immunotherapies using antigen specific regulatory T-cells for severe chronic inflammatory and autoimmune diseases, announces today that it has temporarily put its pilot manufacturing facility activities at Besançon, France on partial hold.
Asthma is a disease that mostly affects young boys and adult women. And according to a new study, women in their 40s and 50s with asthma are hospitalized more than twice as often as men in the same age group. The 10-year study is published in the September issue of Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI).
› Verified 5 days ago
| Entity Name | Fox Valley Surgical Associates Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376594952 PECOS PAC ID: 7911971296 Enrollment ID: O20040823000907 |
News Archive
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the launch of the ICOLabs Medical Review Application an innovative web based laboratory application that enables more efficient use of medical monitoring time.
Novartis announced today that the results of the MEASURE 1 and MEASURE 2 Phase III studies for Cosentyx® (secukinumab) in ankylosing spondylitis (AS) were published in The New England Journal of Medicine (NEJM). These pivotal studies demonstrated significant clinical improvements with Cosentyx versus placebo in reducing the signs and symptoms of active AS – a long-term, painful and debilitating inflammation of the spine.
A new study has demonstrated a way to deliver a nanoparticle-based gene therapy, in order to repair lungs damaged by chronic allergic asthma and to reduce inflammation that causes asthma attacks.
TxCell SA, a biotechnology company developing innovative, personalized T cell immunotherapies using antigen specific regulatory T-cells for severe chronic inflammatory and autoimmune diseases, announces today that it has temporarily put its pilot manufacturing facility activities at Besançon, France on partial hold.
Asthma is a disease that mostly affects young boys and adult women. And according to a new study, women in their 40s and 50s with asthma are hospitalized more than twice as often as men in the same age group. The 10-year study is published in the September issue of Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Charles C Cheng, MD 1818 N Meade St, Suite 240 West, Appleton, WI 54911-3454 Ph: (920) 731-8289 | Charles C Cheng, MD 1818 N Meade St, Suite 240 West, Appleton, WI 54911-3454 Ph: (920) 731-8289 |
News Archive
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the launch of the ICOLabs Medical Review Application an innovative web based laboratory application that enables more efficient use of medical monitoring time.
Novartis announced today that the results of the MEASURE 1 and MEASURE 2 Phase III studies for Cosentyx® (secukinumab) in ankylosing spondylitis (AS) were published in The New England Journal of Medicine (NEJM). These pivotal studies demonstrated significant clinical improvements with Cosentyx versus placebo in reducing the signs and symptoms of active AS – a long-term, painful and debilitating inflammation of the spine.
A new study has demonstrated a way to deliver a nanoparticle-based gene therapy, in order to repair lungs damaged by chronic allergic asthma and to reduce inflammation that causes asthma attacks.
TxCell SA, a biotechnology company developing innovative, personalized T cell immunotherapies using antigen specific regulatory T-cells for severe chronic inflammatory and autoimmune diseases, announces today that it has temporarily put its pilot manufacturing facility activities at Besançon, France on partial hold.
Asthma is a disease that mostly affects young boys and adult women. And according to a new study, women in their 40s and 50s with asthma are hospitalized more than twice as often as men in the same age group. The 10-year study is published in the September issue of Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI).
› Verified 5 days ago
Philip Anthony Vogt, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1818 N Meade St, Ste 240- West, Appleton, WI 54911 Phone: 920-731-8289 Fax: 920-832-0444 | |
Dr. Maykong Leepalao, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1501 S Madison St, Appleton, WI 54915 Phone: 920-730-4435 | |
Dr. Alexander Spencer Tretinyak, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1818 N Meade St, Suite 240 West, Appleton, WI 54911 Phone: 920-731-8131 Fax: 920-832-0444 | |
Beth R Krieger, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1818 N Meade St, Suite 240 West, Appleton, WI 54911 Phone: 920-731-8289 Fax: 920-832-0444 | |
Janeil Mitchell, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1818 N Meade St # 240w, Appleton, WI 54911 Phone: 920-731-8131 | |
Ping D Lady, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1501 S Madison St, Appleton, WI 54915 Phone: 920-730-4435 | |
Tina M. Sauerhammer, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2700 E Enterprise Ave Ste A, Appleton, WI 54913 Phone: 920-965-1234 |